Welcome
Support Centre
12 March 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised study of the postoperative quality of life: laparoscopic UTerine Artery Clipping versus laparoscopy-assisted vaginal hysterectomy for the management of symptomatic uterine fibroids
ISRCTN ISRCTN76790866
ClinicalTrials.gov identifier
Public title A randomised study of the postoperative quality of life: laparoscopic UTerine Artery Clipping versus laparoscopy-assisted vaginal hysterectomy for the management of symptomatic uterine fibroids
Scientific title
Acronym UTAC trial
Serial number at source SNUHOBGY001
Study hypothesis Laparoscopic Uterine Artery Clipping (LUAC) may be an alternative treatment for the improvement of postoperative Quality Of Life (QOL) in patients with symptomatic uterine fibroids, compared with Laparoscopy-Assisted Vaginal Hysterectomy (LAVH).
Ethics approval The ethical committee of Seoul National University College of Medicine and Seoul National University Hospital approved the protocol for this study on the 9th May 2007 (IRB no.: H-0704-032-205).
Study design Randomised controlled study
Countries of recruitment South Korea
Disease/condition/study domain Uterine fibroids
Participants - inclusion criteria 1. Aged greater than or equal to 40 years old
2. Patients who do not want conception any more
3. Patients who agree to this study with informed consent
4. More than 2 cm sized uterine fibroids on Ultrasonography (USG)
5. Uterine fibroids with symptoms such as menorrhagia, dysmenorrhoea, lower abdominal discomfort or pain, lower back pain, urologic problems (dysuria, frequency, etc.,)
6. Patients without underlying disease affecting QOL
7. At least six months interval after last medication, if patients have been treated with Gonadotropin-Releasing Hormone (GnRH) agonists
Participants - exclusion criteria 1. Aged less than 40 years old
2. Patients with subserosal pedunculated fibroid
3. Pregnant women
4. Patients with pelvic inflammatory disease developed within one month
5. Patients with contraindication of surgical treatment
6. Patients with previous history of myomectomy, hysterectomy, myolysis, uterine artery embolisation
7. Less than six months interval after last medication, if patients have been treated with GnRH agonist
8. Patients with underlying disease affecting QOL
Anticipated start date 01/05/2007
Anticipated end date 30/06/2009
Status of trial Completed
Patient information material
Target number of participants Group 1 (LUAC): 30 patients; Group 2 (LAVH): 30 patients
Interventions Group 1: treated with Laparoscopic Uterine Artery Clipping (LUAC)
Group 2: treated with Laparoscopy-Assisted Vaginal Hysterectomy (LAVH)

After both treatments, we will follow up the enrolled patients in this trial during one year. We will compare preoperative and postoperative (after one year) QOLs between two groups.
Primary outcome measure(s) Postoperative quality of life until one year after surgical treatment using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer patients (EORTC QLQ-C30) version 3.0.
Secondary outcome measure(s) 1. Volume reduction of uterus, ovary, and fibroids in Group 1: Volume (cm^3) = length (cm) X width (cm) X depth (cm) X 0.5233, measured every three months till one year
2. Improvement of subjective symptoms in both groups: 11 point symptom score, ranging from -5 (markedly worse) to +5 (markedly better), checked after one year postoperatively
3. Evaluation of postoperative menorrhagia in Group 1: using a simple visual assessment technique, measured monthly using the recording sheet including simple visual assessment technique by herself. After one year postoperatively, we will collect the recording sheets from the patients and analyze the data.
Sources of funding Seoul National University (South Korea) - College of Medicine, Department of Obstetrics and Gynaecology
Trial website
Publications 2009 protocol in http://www.ncbi.nlm.nih.gov/pubmed/19178748
Contact name Prof  Jae Weon  Kim
  Address Department of Obstetrics and Gynecology and Cancer Research Institute
Seoul National University
28 Yungun-Dong
Chongno-Gu
  City/town Seoul
  Zip/Postcode 110-744
  Country Korea, South
Sponsor Seoul National University (South Korea)
  Address c/o Kim Jae Weon
Department of Obstetrics and Gynaecology and Cancer Research Institute
28 Yungun-Dong
Chongno-Gu
  City/town Seoul
  Zip/Postcode 110-744
  Country Korea, South
  Sponsor website: http://www.snu.ac.kr/
Date applied 29/05/2007
Last edited 20/07/2009
Date ISRCTN assigned 25/06/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© ISRCTN


BioMed Central